Advertisement
Advertisement

QTRX

QTRX logo

Quanterix Corporation Common Stock

2.69
USD
Sponsored
+0.05
+1.89%
May 22, 15:59 UTC -4
Closed
exchange

Pre-Market

2.72

+0.03
+1.15%

QTRX Earnings Reports

Positive Surprise Ratio

QTRX beat 17 of 34 last estimates.

50%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$38.82M
/
-$0.45
Implied change from Q1 26 (Revenue/ EPS)
+6.61%
/
+21.62%
Implied change from Q2 25 (Revenue/ EPS)
+58.62%
/
-19.64%

Quanterix Corporation Common Stock earnings per share and revenue

On May 06, 2026, QTRX reported earnings of -0.37 USD per share (EPS) for Q1 26, beating the estimate of -0.55 USD, resulting in a 33.24% surprise. Revenue reached 36.41 million, compared to an expected 37.96 million, with a -4.08% difference. The market reacted with a -16.41% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.45 USD, with revenue projected to reach 38.82 million USD, implying an increase of 21.62% EPS, and increase of 6.61% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.24
Surprise
+41.90%
logo
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.18
Surprise
+6.98%
logo
Valneva SE - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.18
Surprise
-154.60%
logo
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
logo
FitLife Brands, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.12
Actual
$0.17
Surprise
+33.33%
logo
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-
Actual
$0.21
Surprise
-
logo
Veru Inc.
Report Date
May 13, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.12
Surprise
+58.72%
logo
Cytosorbents Corp.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.08
Surprise
-42.60%
logo
Cellectar Biosciences INC NEW
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.92
Actual
-$1.30
Surprise
+32.39%
logo
Innovative Eyewear, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.37
Surprise
+22.82%
FAQ
For Q1 2026, Quanterix Corporation Common Stock reported EPS of -$0.37, beating estimates by 33.24%, and revenue of $36.41M, -4.08% below expectations.
The stock price moved down -16.41%, changed from $3.29 before the earnings release to $2.75 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on -- analysts, Quanterix Corporation Common Stock is expected to report EPS of -$0.45 and revenue of $38.82M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement